Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study
Public ClinicalTrials.gov record NCT00528112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-Center, Open-Label, Randomized Study to Assess the Safety and Contraceptive Efficacy of Two Doses ( in vitro12 µg/24h and 16 µg/24h) of the Ultra Low Dose Levonorgestrel Contraceptive Intrauterine Systems (LCS) for a Maximum of 3 Years in Women 18 to 35 Years of Age and an Extension Phase of the 16µg/24h Dose Group (LCS16 Arm) up to 5 Years
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study on a new low dose levonorgestrel contraceptive intrauterine systems (LCS). The purpose of the study is to investigate which of the 2 administered doses is the lowest effective intrauterine dose of Levonorgestrel (LNG) administered via the LCS for contraception during 3 years. The study was amended: the LCS16 arm will be extended up to 5 years
Study identification
- NCT ID
- NCT00528112
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,885 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 35 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Jun 30, 2011
- Completion
- May 31, 2013
- Last update posted
- Jan 24, 2017
2007 – 2013
United States locations
- U.S. sites
- 57
- U.S. states
- 28
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Glendale | Arizona | 85304 | — |
| Not listed | Phoenix | Arizona | 85032 | — |
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | Carmichael | California | 95608 | — |
| Not listed | Pacific Palisades | California | 90272 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | San Diego | California | 92130 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Denver | Colorado | 80218 | — |
| Not listed | Littleton | Colorado | 80128 | — |
| Not listed | Boyton Beach | Florida | 33472 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Miami | Florida | 33186 | — |
| Not listed | West Palm Beach | Florida | 33409 | — |
| Not listed | Atlanta | Georgia | 30328 | — |
| Not listed | Decatur | Georgia | 30034 | — |
| Not listed | Boise | Idaho | 83702 | — |
| Not listed | Idaho Falls | Idaho | 83404 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Evansville | Indiana | 47714 | — |
| Not listed | South Bend | Indiana | 46601 | — |
| Not listed | Marrero | Louisiana | 70072 | — |
| Not listed | Boston | Massachusetts | 02118 | — |
| Not listed | Kalamazoo | Michigan | 49009 | — |
| Not listed | Chaska | Minnesota | 55318 | — |
| Not listed | Chesterfield | Missouri | 63017 | — |
| Not listed | Lincoln | Nebraska | 68510 | — |
| Not listed | Las Vegas | Nevada | 89106 | — |
| Not listed | Las Vegas | Nevada | 89128 | — |
| Not listed | Las Vegas | Nevada | 89135 | — |
| Not listed | Moorestown | New Jersey | 08057 | — |
| Not listed | New Brunswick | New Jersey | 08903-2685 | — |
| Not listed | Albuquerque | New Mexico | 87102 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | New Bern | North Carolina | 28562 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Columbus | Ohio | 43213 | — |
| Not listed | Medford | Oregon | 97504 | — |
| Not listed | Portland | Oregon | 97239 | — |
| Not listed | Jenkintown | Pennsylvania | 19046 | — |
| Not listed | Philadelphia | Pennsylvania | 19114 | — |
| Not listed | Pittsburgh | Pennsylvania | 15206 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213-3180 | — |
| Not listed | Columbia | South Carolina | 29201 | — |
| Not listed | Chattanooga | Tennessee | 37404 | — |
| Not listed | Memphis | Tennessee | 38119 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Austin | Texas | 78748 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Houston | Texas | 77054 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Seattle | Washington | 98105 | — |
| Not listed | Spokane | Washington | 99207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00528112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00528112 live on ClinicalTrials.gov.